基于 3 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the full record of transactions filed by Cheng Cheung Ling, 管理人员. Director active across 1 company, notably Sino Biopharmaceutical Ltd.. Aggregated, 3 disclosures have been recorded. History available since 28 April 2026. The latest transaction was filed on 30 April 2026 (Purchase). Regulator: HKEX. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Cheng Cheung Ling is an executive at Sino Biopharmaceutical Ltd., a leading company in the pharmaceutical field. He is responsible for overseeing the company's operations and strategy, contributing to its development and innovation in the sector. His expertise enables him to navigate effectively in a complex environment.